期刊文献+

不同糖代谢状态人群胰岛素抵抗和胰岛β细胞功能研究 被引量:30

Insulin resistance and function of islet β cell in Chinese with different status of glucose metabolism
原文传递
导出
摘要 目的 探讨从正常糖耐量到糖尿病 (DM )不同糖代谢水平 ,胰岛素抵抗 (IR)与胰岛 β细胞功能的演变。方法 青岛市区 3 0~ 74岁的正常糖耐量 (NGT ) 44 7例 ;空腹血糖受损 (IFG) 14 2例 ;糖耐量受损 (IGT) 93例 ;IFG合并IGT(IFG +IGT) 42例 ;新诊DM 15 3例。采用HOMA IR评价IR ,HOMA β、ΔI3 0 /ΔG3 0 分别评价基础状态下及糖负荷后的早期胰岛 β细胞功能。 结果 IFG组HOMA IR为 1.14± 0 .0 6,明显高于NGT组的 0 .93± 0 .0 3 (P <0 .0 5 ) ,IFG组HOMA β为 4.5 3± 0 .0 6,低于NGT组 5 .10± 0 .0 4(P<0 .0 5 ) ,两组间△I3 0 /△G3 0 差异无显著性 ( 4 .86± 0 .11vs 4.99± 0 .11) ;IGT组HOMA IR为 1.12± 0 .0 7,明显高于NGT (P <0 .0 5 ) ,两组间HOMA β差异无显著性 ,IGT组△I3 0 /△G3 0 为 4.62± 0 .14 ,低于NGT组的 4.99± 0 .11(P <0 .0 5 ) ;DM组HOMA IR为 1.5 5± 0 .0 5 ,明显高于NGT、IGT和IFG组 (P <0 .0 5 ) ,DM组HOMA β和△I3 0 /△G3 0 分别为 3 .94± 0 .0 6、3 .93± 0 .12 ,明显低于其他各组 (P <0 .0 5 ) ,DM组基础与糖负荷后的胰岛 β细胞功能均明显受损。 结论 IFG患者主要表现 β细胞功能缺陷 ,IGT为胰岛素早期分泌受损 ,DM患者兼有严重的IR和β细胞缺陷。从NGT到DM ,? Objective To investigate the changes of insulin resistance (IR) and function of islet β cell in Chinese with different status of glucose metabolism. Methods Isolated impaired fasting glucose (IFG, n=142), isolated impaired glucose tolerance (IGT, n=93), combined IFG and IGT (IFG+IGT, n=42), newly diagnosed diabetes (DM, n=153) were studied. Subjects of normal glucose tolerance (NGT, n=447) were randomly selected from residents living in the same community of the patients. Fasting, 30 and 120 min plasma glucose and serum insulin during 75 g oral glucose tolerance test (OGTT) were measured. Homeostasis model assessment (HOMA) was applied to assess the status of insulin resistance (HOMA-IR), and HOMA-β and the ratio of the increment of insulin to that of plasma glucose of the initial 30 min during OGTT (△I 30/△G 30) were used to evaluate the basic function and the early phase of insulin secretion of islet β cells respectively. Results As compared with NGT, age, waist circumference, body mass index (BMI), blood pressure, 120 min glucose were elevated in other 4 groups. Adjusted with age and sex, HOMA-IR was higher in subjects with IFG (1.14±0.06), IGT (1.12±0.07) and IFG & IGT than that with NGT (0.93±0.03) (P<0.05), however, there was no difference among IFG, IGT, and IFG & IGT. Compared with subjects in NGT, subjects with IFG had lower HOMA-β(4.53±0.06 vs 5.10±0.04, P<0.05), while there was no difference in △I 30/△G 30. Individuals with IGT showed lower △I 30/△G 30 than that with NGT (4.62±0.14 vs 4.99±0.11, P<0.05), but no difference in HOMA-β. Compared with subjects in IFG, HOMA-β increased in subjects with IGT (5.11±0.07 vs 4.53±0.06, P<0.05), although no difference was found in △I 30/△G 30. At the same time, subjects with DM had more severe IR (1.55±0.05 , P<0.05) and basic and postload dysfunction of β cell compared with other groups (3.94±0.06;3.93±0.12, both P<0.05). Conclusion The individuals with IFG mainly showed defect of basic β cell function, the subjects with IGT showed defect of the early phase of insulin secretion, and the patients with DM have more severe IR and defect of the basic and postload β cell function. With the deterioration of glucose metabolism from NGT to DM, the function of islet β cells is progressively decreased; eventually, failure of islet β cells.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2004年第3期193-196,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 糖代谢 胰岛素抵抗 胰岛Β细胞功能 空腹血糖受损 糖尿病 Insulin resistance β cell function Glucose metabolism
  • 相关文献

参考文献17

  • 1Unwin N,Shaw J,Zimmet P,Alberti KGMM,金文胜,潘长玉.糖耐量低减和空腹血糖受损:定义及干预的现状[J].中华内分泌代谢杂志,2003,19(1). 被引量:92
  • 2Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio heart study. Diabetes Care, 1997,20:1087-1092.
  • 3Phillips DI, Clark PM, Hales CN, et al. Understanding oral glucose tolerance: comparison of glucose of insulin resistance and secretion. Diabet Med , 1994,11:286-292.
  • 4Defronzo RA, Ferrannini E, Simensen DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus, contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism, 1989,38:387-395.
  • 5Pimenta W, Korytkowski M, Mitrakou A, et al. Pancreatic β-cell dysfuction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA, 1995,273:1855-1861.
  • 6Melchionda N, Forlani G, Marchesini G, et al. WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance. Int J Obes Relat Metab Disord, 200
  • 7Li CL, Tsai ST, Chou P. Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment: The Kinmen Study. J Clin Epidemiol, 2002,55:19-24.
  • 8Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes, 1999,48:2197-2203.
  • 9Davies MJ, Raymond NT, Day JH, et al. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med, 2000,17:433-440.
  • 10Unger RH, Faster DW, Diabetes mellitus. In: Wilson JD, et al (eds). Williams textbook of endocrinology. 9th ed. Philadelphia: Saunders, 2001,1008-1009.

二级参考文献20

  • 1Haffner SM, Gonzalez C, Miettinen H, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care, 1996,19:1138-1141.
  • 2Stewart MW, Humphriss DB, Berrish TS, et al. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care, 1995,18:1020-1022.
  • 3Briaud I, Rouault C, Reach G, et al. Long-term exposure of isolated rat islets of Langerhans to supraphysiologic glucose concentrations decreases insulin mRNA levels. Metabolism, 1999,48:319-323.
  • 4Boden G, Ruiz J, Kim CJ, et al. Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. Am J Physiol, 1996,270:E251-E258.
  • 5Swinburn BA, Gianchandani R, Saad MF, et al. In vivo beta-cell function at the transition to early non-insulin-dependent diabetes mellitus. Metabolism, 1995,44:757-764.
  • 6潘孝仁,Diabetes Care,1997年,20卷,537页
  • 7李光伟,中华内科杂志,1993年,32卷,656页
  • 8贾伟平,中国糖尿病杂志,1995年,3卷,11页
  • 9Gomez-Perez FJ,Aguilar-Salinas CA,Lopez-Alvarenga JC,et al.Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care,1998,21:1886-1888.
  • 10Gimeno SG,Ferreira SR ,Franco LJ,et al. Comparison of glucose tolerance categories according to the World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. Diabetes Care, 1998,21 : 1889-1892.

共引文献443

同被引文献237

引证文献30

二级引证文献151

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部